Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

Biogen · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
multiple-sclerosis
relapsing-remitting multiple sclerosis (rrms), multiple sclerosis, daclizumab, tysabri-switch, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 873586
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.